A detailed history of Eastover Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eastover Investment Advisors LLC holds 38,057 shares of ABBV stock, worth $6.68 Million. This represents 3.52% of its overall portfolio holdings.

Number of Shares
38,057
Previous 36,874 3.21%
Holding current value
$6.68 Million
Previous $6.32 Million 18.83%
% of portfolio
3.52%
Previous 3.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $193,822 - $235,807
1,183 Added 3.21%
38,057 $7.52 Million
Q2 2024

Jul 09, 2024

BUY
$154.79 - $180.76 $69,036 - $80,618
446 Added 1.22%
36,874 $6.32 Million
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $82,307 - $93,781
-515 Reduced 1.39%
36,428 $6.63 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $157,689 - $177,595
1,146 Added 3.2%
36,943 $5.73 Million
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $88,703 - $102,687
664 Added 1.89%
35,797 $5.34 Million
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $548,591 - $682,686
-4,140 Reduced 10.54%
35,133 $4.73 Million
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $40,056 - $46,131
277 Added 0.71%
39,273 $6.26 Million
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $40,524 - $48,599
293 Added 0.76%
38,996 $0
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $56,099 - $64,342
418 Added 1.09%
38,703 $5.37 Million
Q2 2022

Jul 26, 2022

SELL
$137.62 - $174.96 $1.98 Million - $2.52 Million
-14,420 Reduced 27.36%
38,285 $5.86 Million
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $507,463 - $629,618
3,845 Added 7.87%
52,705 $8.54 Million
Q4 2021

Jan 12, 2022

BUY
$107.43 - $135.93 $77,242 - $97,733
719 Added 1.49%
48,860 $6.62 Million
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $60,116 - $68,240
565 Added 1.19%
48,141 $5.19 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $219,362 - $244,382
2,085 Added 4.58%
47,576 $5.36 Million
Q1 2021

Apr 19, 2021

SELL
$102.3 - $112.62 $322,347 - $354,865
-3,151 Reduced 6.48%
45,491 $4.92 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $18,512 - $24,994
-230 Reduced 0.47%
48,642 $5.21 Million
Q3 2020

Oct 20, 2020

BUY
$85.91 - $100.83 $64,862 - $76,126
755 Added 1.57%
48,872 $4.28 Million
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $61,924 - $82,863
844 Added 1.79%
48,117 $4.72 Million
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $3.05 Million - $4.62 Million
47,273 New
47,273 $3.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Eastover Investment Advisors LLC Portfolio

Follow Eastover Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastover Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eastover Investment Advisors LLC with notifications on news.